Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 4, 1999

View Archived Issues

EuropaBio Defends Industry, Proposes Centralized System

Atugen Gains U.S. Presence Via Collaboration, Subsidiary

Obesity Drugs Could Spring From Discovery Of Receptor

Biota Gets Much Of Value Back After U.S. Approval Of Relenza

CellStain Nears Full Trials Of Broad Cancer Diagnostic

Cantab Drops Vaccine Work In Chicken Pox, Shingles

Xenome Receives Investment From Medica For Pain Drug

Neurochem, Resolution Align To Detect Alzheimer's Early

UK Considers Allowing Secrecy Following Greenpeace Incident

Oxford Asymmetry Grows Despite Struggles In UK

BioLitec Moves Forward In Photodynamic Therapy

Alizyme Demonstrates Delivery To Colon Of Steroid Product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...